Authors:
LUBLIN FD
REINGOLD SC
CLANET M
COOKFAIR D
EBERS G
GOODKIN D
HARTUNG HP
LISAK R
MCDONALD WI
MCFARLAND H
NOSEWORTHY J
PANITCH H
POLMAN C
REDER A
RUDGE P
SIBLEY W
WHITAKER J
WOLINSKY J
Citation: Fd. Lublin et al., GUIDELINES FOR CLINICAL-TRIALS OF NEW THERAPEUTIC AGENTS IN MULTIPLE-SCLEROSIS - RELATIONS BETWEEN STUDY INVESTIGATORS, ADVISERS, AND SPONSORS, Neurology, 48(3), 1997, pp. 572-574
Authors:
MILLER DH
ALBERT PS
BARKHOF F
FRANCIS G
FRANK JA
HODGKINSON S
LUBLIN FD
PATY DW
REINGOLD SC
SIMON J
Citation: Dh. Miller et al., GUIDELINES FOR THE USE OF MAGNETIC-RESONANCE TECHNIQUES IN MONITORINGTHE TREATMENT OF MULTIPLE-SCLEROSIS, Annals of neurology, 39(1), 1996, pp. 6-16
Citation: Fd. Lublin et Sc. Reingold, DEFINING THE CLINICAL COURSE OF MULTIPLE-SCLEROSIS - RESULTS OF AN INTERNATIONAL SURVEY, Neurology, 46(4), 1996, pp. 907-911
Citation: Sc. Reingold, ADVANCES IN THE UNDERSTANDING AND TREATMENT OF MULTIPLE-SCLEROSIS - BOSTON, MASSACHUSETTS, USA, 28-29 OCTOBER 1992, Journal of neuroimmunology, 44(2), 1993, pp. 221-224
Authors:
RAO SM
REINGOLD SC
RON MA
LYONCAEN O
COMI G
Citation: Sm. Rao et al., WORKSHOP ON NEUROBEHAVIORAL DISORDERS IN MULTIPLE-SCLEROSIS - DIAGNOSIS, UNDERLYING DISEASE, NATURAL-HISTORY, AND THERAPEUTIC INTERVENTION,BERGAMO, ITALY, JUNE 25-27, 1992, Archives of neurology, 50(6), 1993, pp. 658-662